Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors
The sphingosine-1-phosphate (S1P) pathway remains an active area of research for drug discovery because S1P modulators are effective medicine for autoimmune diseases such as multiple sclerosis and ulcerative colitis. As such, other nodes in the pathway can be probed for alternative therapeutic candi...
Main Authors: | Yugesh Kharel, Tao Huang, Webster L. Santos, Kevin R. Lynch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | SLAS Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2472555223000503 |
Similar Items
-
New insights into functions of the sphingosine-1-phosphate transporter SPNS2
by: Sarah Spiegel, et al.
Published: (2019-03-01) -
Spinster homolog 2/S1P signaling ameliorates macrophage inflammatory response to bacterial infections by balancing PGE2 production
by: Chao Fang, et al.
Published: (2024-09-01) -
Functional cooperation of spns2 and fibronectin in cardiac and lower jaw development
by: Yu Hisano, et al.
Published: (2013-06-01) -
Spns2 Transporter Contributes to the Accumulation of S1P in Cystic Fibrosis Human Bronchial Epithelial Cells
by: Aida Zulueta, et al.
Published: (2021-08-01) -
Spinster homolog 2 (SPNS2) deficiency drives endothelial cell senescence and vascular aging via promoting pyruvate metabolism mediated mitochondrial dysfunction
by: Haojun Tang, et al.
Published: (2024-10-01)